NCT01220154 - Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 28, 2011

Primary Completion Date

July 17, 2023

Study Completion Date

July 17, 2023

Conditions

Ovarian CancerFallopian Tube CancerPrimary Peritoneal CancerNo Prior Chemotherapy

Interventions

DRUG

Paclitaxel

Cycle 1 Day 1, 8, 15 IV 60-80mg mg/m2 as a 1 hour infusion. For cycle 2-6 Day 1,8,15 IV 60-80 mg/m2 as 1 hour infusion. Repeat every 3 weeks times 5 cycles.

DRUG

Carboplatin

Intraperitoneal Day 1 cycles 1-6 AUC

DRUG

Bevacizumab

Bevacizumab 15 mg/kg intravenous infusion Day 1 cycles 2-6 Optional cycles 7-22 15 mg/kg intravenous infusion Day 1 every 21 days

Trial Locations (1)

43026

OSU Gyn Oncology at Mill Run, Hilliard